Evaluation of Neutralizing Capacity of Different Commercial Brands of Antacid Tablets
Evaluation of Neutralizing Capacity of Different Commercial Brands of Antacid Tablets
Evaluation of Neutralizing Capacity of Different Commercial Brands of Antacid Tablets
G E RI A
C H E M IC
Received: 10/10/2015 Accepted: 31/10/2015 C .S.N
A
NI
http://dx.doi.org/10.4314/csj.v6i2.6 LS
OCI ET Y OF
ABSTRACT
This study is based on the evaluation of acid neutralizing capacity of five different commercial brands of antacid
tablets. Five different but widely used commercial antacid tablets were selected for the purpose of this study.
Each of the sample tablets was purchased, crushed, weighed and kept at room temperature before being
analyzed using titrimetric method. Titration of each sample tablet (0.5 g) dissolved in 20 cm 3 of 0.1 M HCl with
0.1 M NaOH was carried out and the average titer values of different runs were recorded. The titre value for
Gaviscon was 9.20 cm3, 13.04 cm3 for Gestid, 10.02 cm3 for Danacid, 10.10 cm3 for Cimetidine and 10.05 cm3
for Rennietidine. The neutralizing capacity (NC) of Gaviscon was found to be 82.6%, 53.4% for Gestid, 64.8%
for Danacid, 49.8% for Cimetidine and 36.6% for Rennietidine. Analysis of the results shows that Gaviscon
tablet has the highest NC, while Rennietidine shows lower NC value.
According to the results obtained in the compared to other antacids used in the study.
analysis of different brands of antacid tablets Similarly, less amount of Gaviscon is needed to
(Table 1), it was clear that Gaviscon tablet shows neutralize same amount of HCl compared to the
lower average titer value of 9.20 cm3, while Gestid rest of the antacids used in the study.
tablet has the highest average titer value of 13.04 The total amount of HCl (mole) used was
cm3. This indicate that Gaviscon with the lower determined using the equation (1), while the
average titre value records the highest value of the amount of HCl (mole) neutralized by NaOH was
excess HCl neutralized, while Gestid with the determined using the expression (2). The amount of
highest titre value records the lowest value of the excess HCl neutralized by antacid was determined
excess HCl neutralized. This means more amount by subtracting the amount of HCl neutralized by
Gestid is needed to neutralize same amount of HCl
33
CSJ 6(2): December, 2015 ISSN: 2276 – 707X Abdu and Abbagana
NaOH from the total amount of HCl used as represented by equation (3), (Heriro, et al., 1997).
…… (1)
….(2)
Excess HCl neutralized by antacid = M (HCl ) – M (HCl neutralized by NaOH) ……… (3)
The moles of excess HCl neutralized was Mg(OH)2; Danacid has Mg2O8Si3 and Al(OH)3;
multiplied by the molar mass of the antacid and in Rennietidine has CaCO3 and MgCO3; while
order to get the moles of excess HCl per molar Cimetidine has C10H16N6S.
mass unit of the antacid. Percentage of the excess HCl neutralized or the
Each antacid tablet has different active ingredient, neutralizing capacity was calculated for each brand
so for Gavison contains NaHCO3, CaCO3 and of antacids as follows;
NaC6H7O6; Gestid has Mg2O8Si3, Al(OH)3 and
Therefore, it was clear from the results Pali-Scholl I. and Jensen–Jarolim E. (2011): Anti-
that Gaviscon gives the highest neutralizing acid medication as a risk factor for food
capacity of 82.6% while, Rennietidine represent the allergy. Allergy 66 (4): 469-77.
tablet with lowest neutralizing capacity of 36.6%. Smith, R.D., Herzeg, T., Wheatley, T.A., Hause,
W. and Reavey-Cantewell, N.H. (1976): An in
CONCLUSION vitro evaluation of the efficacy of the more
From the results shown it was clear that frequently used antacids with particular
Gaviscon tablet is more active, because it attention to tablets. J. Pharm. Sci. 65, 1045-
neutralized more amount of acid than the rest. It is 1047.
recommended that further work should be carried Van Dop, C., Overvliet, G.M. and Smits, H.M.
out on other antacid drugs particularly on the (1976): Quality control of antacids. Pharm
enzymatic assay, cytotoxicity and tissue absorption weekblad, 111, 748-750.
to fully ascertain their neutralizing capacity. van Reit-Nales, D.A, van Alst, P., de Caste, D.,
Barend, D.M. (2002): An improved in vitro
REFERENCES method for the evaluation of antacids with in
Duffy, T.D., Fawzy, Z.S., Ireland, D.S. and vivo relevance. Eur. J. Pharm. & Biopharm.
Rubinstein, M.H. (1982): A comparison, 53, 217-223.
evaluation of liquid antacids commercially Zajac, P., Holbrook, A., Super, M.E. and Vogt, M.
available in the United Kingdom. J. Clinic. (2013): An overview: current clinical guide
Hospt. Pharm. 7, 53-58. lines for the evaluation, diagnosis, treatment
Farzaei, M.H., Mohammad, R.S., Zahra, A. and and management of dyspepsia. Osteopathic
Roja, R. (2013): Scientific evaluation of edible family physician 5 (2) 79-85.
fruits and spices used for the treatment of
peptic ulcer in traditional Iranian medicine.
Gastroenteroly 2, 1-12.
Herrero, A., Cloquell, G. and Amela, J. (1997):
Evaluation of the in vitro activity of several
antacids preparations. Drug Dev. Ind. Pharm.
23, 369-374.
Lin, M.S., Sun, P. and Yu, H.Y. (1998): Evaluation
of buffering capacity and acid neutralizing pH
time profile of antacids. J. Fosmos Med. Assoc.
77, 704-710.
34